WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

Alterations in ATCvet codes

 Alterations included in the ATCvet Index valid from 2013

Previous ATCvet codeATCvet level name New ATCvet code
QA03AE04prucaloprideQA06AX05
QA03AE02tegaserodQA06AX06
QB01AX06rivaroxabanQB01AF01
QJ05AE06lopinavir and ritonavir 1)QJ05AR10
QL01XE90masitinibQL01XE22
QH01CA03histrelinQL02AE05
QN01AX01droperidolQN05AD08 (existing code)
QN02AA09diamorphineQN07BC06
QP53BD01methopreneQP53AX28
QP53BD51methoprene, combinationsQP53AX78
QS01AX11ofloxacinQS01AE01
QS01AX12norfloxacinQS01AE02
QS01AX13ciprofloxacinQS01AE03
QS01AX17lomefloxacinQS01AE04
QS01AX19levofloxacinQS01AE05
QS01AX21gatifloxacinQS01AE06
QS01AX22moxifloxacinQS01AE07
QS01AX23besifloxacinQS01AE08

Other alterations in ATCvet 2013

Alterations included in the ATCvet Index valid from 2013

ATCvet codePrevious ATCvet level name New ATCvet level name or new ATCvet level
QA03ADrugs for functional bowel disordersDrugs for functional gastrointestinal disorders
QA03AEDrugs acting on serotonin receptorsSerotonin receptor antagonists
QA03AXOther drugs for functional bowel disordersOther drugs for functional gastrointestinal disorders
QA06LaxativesDrugs for constipation
QA06ALaxativesDrugs for constipation
QA06ACBulk producersBulk-forming laxatives
QA06AXOther laxativesOther drugs for constipation
QA16QADrugs for treatment of acetonemiaDrugs for prevention and/or
treatment of acetonemia
QB01AFDirect factor Xa inhibitors
QD03AX11tetrachlorodecaoxidesodium chlorite
QG03AA01etynodiol and estrogenetynodiol and ethinylestradiol
QG03AA02quingestanol and estrogenquingestanol and ethinylestradiol
QG03AA03lynestrenol and estrogenlynestrenol and ethinylestradiol
QG03AA04megestrol and estrogenmegestrol and ethinylestradiol
QG03AA05norethisterone and estrogennorethisterone and ethinylestradiol
QG03AA06norgestrel and estrogennorgestrel and ethinylestradiol
QG03AA07levonorgestrel and estrogenlevonorgestrel and ethinylestradiol
QG03AA08medroxyprogesterone and estrogenmedroxyprogesterone and ethinylestradiol
QG03AA09desogestrel and estrogendesogestrel and ethinylestradiol
QG03AA10gestodene and estrogengestodene and ethinylestradiol
QG03AA11norgestimate and estrogennorgestimate and ethinylestradiol
QG03AA12drospirenone and estrogendrospirenone and ethinylestradiol
QG03AA13norelgestromin and estrogennorelgestromin and ethinylestradiol
QG03AA14nomegestrol and estrogennomegestrol and estradiol
QG03AA15chlormadinone and estrogenchlormadinone and ethinylestradiol
QG03AB01megestrol and estrogenmegestrol and ethinylestradiol
QG03AB02lynestrenol and estrogenlynestrenol and ethinylestradiol
QG03AB03levonorgestrel and estrogenlevonorgestrel and ethinylestradiol
QG03AB04norethisterone and estrogennorethisterone and ethinylestradiol
QG03AB05desogestrel and estrogendesogestrel and ethinylestradiol
QG03AB06gestodene and estrogengestodene and ethinylestradiol
QG03AB07chlormadinone and estrogenchlormadinone and ethinylestradiol
QG03AB08dienogest and estrogendienogest and estradiol
QG04B Other urologicals, incl. antispasmodicsUrologicals
QG04BDUrinary antispasmodicsDrugs for urinary frequency and incontinence
QJ01DIOther cephalosporinsOther cephalosporins and penems
QP53BDInsect growth regulators, excl. chitin synthesis inhibitorsDeleted
QS01AEFluoroquinolones
QV04CHTests for renal functionTests for renal function and ureteral injuries
1) New ATC level name (previous name: lopinavir)

Last updated: 2013-01-24